These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28818991)

  • 1. Immune Modulation Therapy and Imaging: Workshop Report.
    Shields AF; Jacobs PM; Sznol M; Graham MM; Germain RN; Lum LG; Jaffee EM; de Vries EGE; Nimmagadda S; Van den Abbeele AD; Leung DK; Wu AM; Sharon E; Shankar LK
    J Nucl Med; 2018 Mar; 59(3):410-417. PubMed ID: 28818991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of tumour response to immunotherapy.
    Dromain C; Beigelman C; Pozzessere C; Duran R; Digklia A
    Eur Radiol Exp; 2020 Jan; 4(1):2. PubMed ID: 31900689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-Directed Molecular Imaging Biomarkers.
    Pandit-Taskar N; Postow MA
    Semin Nucl Med; 2020 Nov; 50(6):584-603. PubMed ID: 33059826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Imaging in Immunotherapy.
    Eleneen Y; Colen RR
    Adv Exp Med Biol; 2017; 995():141-153. PubMed ID: 28321816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy.
    Solinas C; Porcu M; Hlavata Z; De Silva P; Puzzoni M; Willard-Gallo K; Scartozzi M; Saba L
    Crit Rev Oncol Hematol; 2017 Dec; 120():13-21. PubMed ID: 29198327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging to enlighten cancer immunotherapies and underlying involved processes.
    van der Veen EL; Bensch F; Glaudemans AWJM; Lub-de Hooge MN; de Vries EGE
    Cancer Treat Rev; 2018 Nov; 70():232-244. PubMed ID: 30308466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Response to Immunotherapy Using Standard of Care and Experimental Imaging Approaches.
    Flavell RR; Evans MJ; Villanueva-Meyer JE; Yom SS
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):242-257. PubMed ID: 32585333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of cancer immunotherapy.
    Tumeh PC; Radu CG; Ribas A
    J Nucl Med; 2008 Jun; 49(6):865-8. PubMed ID: 18511842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo imaging of tumor-infiltrating immune cells: implications for cancer immunotherapy.
    Zeelen C; Paus C; Draper D; Heskamp S; Signore A; Galli F; Griessinger CM; Aarntzen EH
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):56-77. PubMed ID: 29191000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Imaging in Immunotherapy.
    Ayoub M; Eleneen Y; Colen RR
    Adv Exp Med Biol; 2020; 1244():309-324. PubMed ID: 32301025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications.
    Decazes P; Bohn P
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32041105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.
    Nishino M; Hatabu H; Hodi FS
    Radiology; 2019 Jan; 290(1):9-22. PubMed ID: 30457485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled antibodies for cancer imaging and therapy.
    Barbet J; Bardiès M; Bourgeois M; Chatal JF; Chérel M; Davodeau F; Faivre-Chauvet A; Gestin JF; Kraeber-Bodéré F
    Methods Mol Biol; 2012; 907():681-97. PubMed ID: 22907380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging.
    Maute RL; Gordon SR; Mayer AT; McCracken MN; Natarajan A; Ring NG; Kimura R; Tsai JM; Manglik A; Kruse AC; Gambhir SS; Weissman IL; Ring AM
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6506-14. PubMed ID: 26604307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging the immune response to monitor tumor immunotherapy.
    Wang Q; Ornstein M; Kaufman HL
    Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking cellular and immune therapies in cancer.
    Kurtz DM; Gambhir SS
    Adv Cancer Res; 2014; 124():257-96. PubMed ID: 25287692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessing Patterns of Response to Immunotherapy with PET: From Morphology to Metabolism.
    Costa LB; Queiroz MA; Barbosa FG; Nunes RF; Zaniboni EC; Ruiz MM; Jardim D; Gomes Marin JF; Cerri GG; Buchpiguel CA
    Radiographics; 2021; 41(1):120-143. PubMed ID: 33275541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Medicine in Pediatric and Adolescent Tumors.
    Kiratli PÖ; Tuncel M; Bar-Sever Z
    Semin Nucl Med; 2016 Jul; 46(4):308-23. PubMed ID: 27237441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing liquid biopsies into clinical decision making for cancer immunotherapy.
    Quandt D; Dieter Zucht H; Amann A; Wulf-Goldenberg A; Borrebaeck C; Cannarile M; Lambrechts D; Oberacher H; Garrett J; Nayak T; Kazinski M; Massie C; Schwarzenbach H; Maio M; Prins R; Wendik B; Hockett R; Enderle D; Noerholm M; Hendriks H; Zwierzina H; Seliger B
    Oncotarget; 2017 Jul; 8(29):48507-48520. PubMed ID: 28501851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.